Shares in Itaconix PLC (AIM:ITX, OTCQB:ITXXF) jumped 15% to 123.47p after the specialty chemicals group said it was entering 2026 from a position of strength, following a third consecutive year of record revenues.
The AIM-listed company, which makes plant-based polymers for use in everyday consumer products, said the board remained optimistic about the year ahead.
It pointed to a growing customer pipeline, wider adoption of its products and what it described as a scalable, capital-efficient business model. More detail on trading and the outlook is due with full-year results in late March.
The upbeat tone follows a milestone year in 2025. Unaudited revenues rose 59% to $10.3 million, up from $6.5 million in 2024, taking annual sales above $10 million for the first time.
Growth was driven by a third consecutive record half-year, with revenues of $5.5 million in the second half, compared with $4.8 million a year earlier.
Momentum came from both new and existing customers across multiple regions and applications.
Demand for Itaconix’s patented plant-based polymers has been rising as large consumer goods groups look to replace traditional ingredients with more sustainable alternatives that still meet performance requirements.
The materials are used in products such as detergents, hygiene items and beauty formulations.
Management said the step-change in commercial traction had allowed the company to invest further in demand generation and customer support ahead of 2026, without stretching the balance sheet.
John Shaw, chief executive, said 2025 marked a turning point for the business. “Delivering record revenues of over $10 million for the first time, alongside our third consecutive record half year, demonstrates the accelerating commercial momentum behind our technology and customer proposition,” he said.
“We are seeing growing validation from both new and existing customers as our plant-based specialty polymers become embedded in next-generation consumer products where performance, sustainability and value are all critical.”
Looking ahead, Shaw said the company was well funded and capital efficient, with a deepening pipeline of opportunities. “With increasing scale, disciplined execution and strong customer engagement, we believe the company is firmly on track towards building a large, profitable and enduring specialty ingredients business,” he added.